Mattel, Brinker International, Vertex Downgraded

Analysts downwardly revised their ratings and price targets on Fisher-Price parent Mattel, Inc. (MAT), restaurant stock Brinker International, Inc. (EAT), and biotech Vertex Pharmaceuticals Incorporated (VRTX)

by Celeste Taylor

Published on Jan 26, 2017 at 11:04 AM

Analysts are weighing in on Fisher-Price parent Mattel, Inc. (NASDAQ:MAT), restaurant stock Brinker International, Inc. (NYSE:EAT), and biotech Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Here's a quick look at today's bearish brokerage notes on MAT, EAT, and VRTX.

Mattel Cut to "Neutral" at MKM Partners

MAT is down 14.3% at $27.05, after the company reported an earnings miss, with the results pressured by a global decline in Fisher-Price and Barbie sales. MKM Partners downgraded MAT to "neutral" from "buy," and joined a number of other brokerage firms in cutting its price target. Today's drop puts MAT down nearly 21% since its mid-August peak near $34.25. In the option pits, near-term traders are more call-skewed now than they've been at any other point during the past year, with MAT's Schaeffer's put/call open interest ratio (SOIR) of 0.24 sitting at an annual low.

Post-Earnings Analyst Backlash for Brinker

After plunging 6.2% yesterday following an earnings miss, EAT is up 1.3% at $44.83 -- which isn't too surprising considering the stock's 14-day Relative Strength Index (RSI) settled at 23, well into oversold territory. Today's bounce comes despite a round of bearish brokerage attention, with EAT receiving no fewer than nine price-target cuts, including one to $43 from $56 at Canaccord Genuity, which said "top-line challenges are likely to persist." Brinker International, Inc.'s withstanding trend has been to the downside, though, with the stock down nearly 20% since touching an annual high of $55.84 in November.

Vertex Attracts Mixed Analyst Attention Post-Earnings

VRTX is down 0.8% at $84.49, after Jefferies and Goldman Sachs cut their respective price targets to $100 and $78, following the company's earnings report and full-year guidance. Leerink, meanwhile, hiked its price target to $115. VRTX shares are staring up at their 200-day moving average, and have a year-over-year loss of 8.5%. Option traders have been buying to open calls over puts at a rapid-fire rate in recent months. VRTX's 50-day call/put volume ratio of 3.84 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is ranked just 2 percentage points from an annual peak.

Find out where the Dow lands right after the closing bell. Sign up now for Schaeffer's Market Recap

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
Google Postpones Android Reveal, "Now is Not the Time to Celebrate"
"Now is not the time to celebrate," Google said in a message on its website
ZNGA Zooms to 8-Year High on Billion-Dollar Deal
ZNGA is planning to buy Peak for $1.8 billion
Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....